⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
AI in Clinical Trials Market Research 2026: Market to Reach $18.62 Billion by 2040 with IQVIA, Medidata, IBM Watson, Oracle, and Phesi Leading Through Integrated Data and Patient Matching Platforms
globenewswire.com
IQV
DSY
IBM
ORCL
PFE
NVS
AI
Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
globenewswire.com
JNJ
BMY
PFE
BAX
GSK
SUN
A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall
globenewswire.com
AMGN
BMY
EXEL
EXAS
GENK
GSK
JNJ
MRK
NTRA
PFE
One in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data
globenewswire.com
BMY
PFE
ABBV
AMGN
PADCEV ™ + Keytruda ® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
businesswire.com
PFE
PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
globenewswire.com
MDBH
LLY
NVO
PFE
AZN
GILD
GPCR
Bayer’s XOFIGO ® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases
businesswire.com
PFE
The International Myeloma Foundation Invites the Myeloma Community to Demonstrate the Spirit of #MoreThanMyeloma for 2026 Myeloma Action Month
globenewswire.com
GSK
JNJ
PFE
REGN
SNY
AMTX
ATHA
TMO
GILD
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen
businesswire.com
PFE
GSK
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing
businesswire.com
PFE
GSK